Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisMelphalanAntigens, CD34Blood Component RemovalHematologic NeoplasmsCombined Modality TherapyStem Cell TransplantationCyclophosphamideMultiple MyelomaGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsBusulfanGraft SurvivalMyeloablative AgonistsBone Marrow TransplantationTreatment OutcomeLymphoma, Non-HodgkinStem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceIfosfamideCarmustineCord Blood Stem Cell TransplantationCytophagocytosisSalvage TherapyHematopoiesisTissue DonorsVincristineAmyloidosisCytarabineTransplantation ChimeraDisease-Free SurvivalHodgkin DiseaseRetrospective StudiesSurvival RateNeoplasmsWhole-Body IrradiationInfectionHistocompatibilityBlood Cell CountTime FactorsBlood CellsPlatelet CountSurvival AnalysisPOEMS SyndromeHistocompatibility TestingImmunosuppressive AgentsDoxorubicinLymphoma, T-CellVidarabineTransplantation, IsogeneicCarboplatinLeukemia, Myeloid, AcuteBone Marrow PurgingLeukemiaRecombinant ProteinsPrednisoneDexamethasoneFollow-Up StudiesCytomegalovirus InfectionsLymphomaFeasibility StudiesProspective StudiesGraft vs Leukemia EffectAntineoplastic AgentsImmunophenotypingFatal OutcomeAnemia, AplasticBlood DonorsLeukocytes, MononuclearMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionBone MarrowCell SeparationT-LymphocytesHematologic DiseasesCyclosporineHistiocytosis, Non-Langerhans-CellFlow CytometryEmbryonic Stem CellsOpportunistic InfectionsBone Marrow DiseasesImmunomagnetic SeparationHLA AntigensLivedo ReticularisLeukocyte CountImmunosuppressionPrecursor Cell Lymphoblastic Leukemia-Lymphoma